Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Rifaximin for the Treatment of Irritable Bowel Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00259155
Recruitment Status : Completed
First Posted : November 29, 2005
Last Update Posted : March 18, 2008
Sponsor:
Collaborators:
University of Chicago
Bausch Health Americas, Inc.
Information provided by:
Cedars-Sinai Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2007
Actual Study Completion Date : January 2007